期刊文献+

TACE对肝癌细胞P-GP表达的影响 被引量:1

Effect of Transcatheter Arterial Chemoembolization on P-glycoprotein Expression in Hepatocellular Carcinoma
下载PDF
导出
摘要 目的分析肝动脉栓塞化疗(TACE)对肝癌细胞多药耐药基因表达产物P糖蛋白(P-GP)的表达影响,P-GP和肝癌预后的关系,从耐药基因角度评价TACE对肝癌治疗的价值。方法采用免疫组织化学S-P法检测30例肝动脉栓塞化疗后二期切除的原发性肝癌(HCC)及癌旁组织中P-GP的表达情况,并以本课题前期研究的30例未经TACE治疗的HCC及癌旁组织中P-GP表达情况作对照。结果 TACE后P-GP在HCC和癌旁组织中阳性率分别为93.3%(28/30)、56.7%(17/30),与未做TACE的阳性率[83.3%(25/30)、30.0%(9/30)]相比,差异均有统计学意义(P<0.05)。P-GP阳性病例比P-GP阴性病例生存时间短,P-GP表达不同的肝细胞肝癌病人的生存时间有差别(P<0.05)。结论 P-GP参与介导HCC的多药耐药,TACE后肝癌细胞P-GP表达阳性率明显增高,TACE后导致继发性多药耐率增高。P-GP的表达有一定的预后判断意义。 Objective To investigate the effect of transcatheter arterial chemoembolization(TACE)on p-glycoprotein(P-GP) expression in hepatocellular carcinoma(HCC),and to explore the relationship between P-GP and HCC prognosis and the value of TACE in the treatment of HCC.Methods The expression of P-GP in 30 cases of secondarily resected HCC and adjacent tissues after TACE(TACE group) was measured by immunohistochemistry(S-P) method and was compared with 30 cases of resected HCC and adjacent tissues managed without TACE(control group).Results Compared with the control group,TACE significantly increased the positive rates of P-GP expression in HCC and adjacent tissues(93.3% vs 83.3% and 56.7% vs 30.0%,respectively;P〈0.05).The average survival rate in P-GP positive patients was lower than that in P-GP negative patients(P〈0.05).Conclusion P-GP may play an important role in multidrug resistance of HCC.TACE can increase P-GP expression and secondary resistance,and the detection of P-GP expression has value to estimate the prognosis in patients with HCC.
出处 《实用临床医学(江西)》 CAS 2011年第5期4-7,共4页 Practical Clinical Medicine
关键词 肝细胞肝癌 肝动脉栓塞化疗 P糖蛋白 多药耐药 免疫组织化学 hepatocellular carcinoma transcatheter arterial chemoembolization P-GP multidrug resistance immunohistochemistry
  • 相关文献

参考文献11

  • 1邬林泉,戈华平,罗志强,傅华群,蒋筱强.NF-κB与P-gP在肝细胞肝癌组织中的表达[J].中华肝胆外科杂志,2007,13(5):314-316. 被引量:6
  • 2Wartenberg M, Ling F C, schallenberg M, et al. Down-regula- tion of intrinsic p-glyeoprotein expression in multieellular pros- tate tumor spheroids by reactive oxygen species[J]. J Biol Chem,2001,276(20) : 17420-17428.
  • 3Bentires AIj M, Barbu V, Fillet M, et al. NF-κB transcription factor induces drug resistance though MDR1 expression in cancer eells[J]. Oneogene, 2003,22 ( 1 ) : 90-97.
  • 4Calcana A, Arancia G, Marra M, et al. Enzymatic oxidation products of sperrnine induce greater cytotoxic effects on hu- man multidrug-resistant colon eareinorna cells (LOVO) them on their wild-type counterparts[J]. Intt J Cancer, 2002, 99 (1):43-52.
  • 5刘瑞宝,徐克,张曦彤,冯博,赵仲春,苏红英.原发性肝癌中多药耐药基因表达及其对介入治疗疗效的影响[J].中国医学影像技术,2003,19(5):617-619. 被引量:4
  • 6Horio M,Gottesman M M, Pastan I. ATP dependent transport of vinblastine in vesicles from human multidrug-resistant cells [J]. Proc Natl Acad Sei USA, 1988,85(10) :3580.
  • 7Aszalos A,Ross D D. Biochemical and clinical aspects of efflux pump-related resistance to anti-cancer drugs [J]. Anticancer Res, 1998,8(40) :2937-2944.
  • 8Beck W T,Grogan T M,Willman C L,et al. Methods to detect P-glycoprotein associated multidrug resistance in patient ' s tumors: comsensus recommendations[J]. Cancer Res, 1996,56 (13) ;3010-3020.
  • 9Sinicrope F A, Hart J, Brasitus T A, et al. Relationship of Pglycoprotein and carcinoembryonic antigen expression in hu- man colon carcinoma to local invasion DNA ploidy,and disease relapse[J]. Cancer, 1994,74 (11) : 2908.
  • 10Duensing S, Dallmann I, Grosse J, et al. Immunocytochemical detection of P-glycoprotein initial expression correlates with survival in renal cell carcinoma patients[J]. Oncology, 1994, 51(4) :309.

二级参考文献18

  • 1[1]Ueno K,Miyazono N,Inoue H,et al. Transcatheter Arterial Chemoembolization Therapy Using Iodized Oil for Patients with Unrespectable Hepatocellular Carcinoma Evaluation of Three Kinds of Regimens and Analysis of Prognostic Factors [J]. Cancer,2000,88(7): 1574-1581.
  • 2[4]Irene OL NG,Chi L Liu,Sheung T Fan,et al. Expression of P-Glycoprotein in Hepatocellular Carcinoma A Determinant of Chemotherapy Response [J]. Am J Clin Pathol,2000,113(3):355-363.
  • 3[5]Biedler JL. Genetic aspects of multdrug resistance [J]. Cancer,1992,70(6):1799-1809.
  • 4[6]Itsubo M,Ishikawa T,Toda G,et al. Immunohistochemical Study of Expression and Cellular Localization of the Multidrug Resistance Gene Product P-Glycoprotein in Primary Liver Carcinoma [J]. Cancer,1994,73(1):298-303.
  • 5Hodge JC, Bub J, Kaul S, et al. Requirement of RhoA activity for increased nuclear factor kappa B activity and PC-3 Human prostate cancer cell invasion. Cancer Res, 2003, 63:1359-1364.
  • 6Baeuerle PA, Baltimore D. NF-kappaB: ten years after. Cell,1996, 87:13 20.
  • 7Beck WT, Grogan TM. Methods to detect P-glycoprotein associated multidrug resistance in patient's tumors: consensus recommendations. Cancer Res, 1996, 56: 3010-3020.
  • 8Fojo AT, Herweijer H. Multidrug resistance genes in human cancer. BrJ Cancer, 1991, 63:663-669.
  • 9Bentires AM, Barbu V, Fillet M, et al. NF-κB transcription factor induces drug resistance through MDR1 expression in cancer cells. Oncogene, 2003, 22: 90-97.
  • 10Kuo MT, Liu Z, Wei Y, et al. Induction of human MDR1 gene expression by 2-acelylaminofluoxene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling. Oncogene, 2002, 21: 1945-1954.

共引文献8

同被引文献6

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部